NCT07610993

Brief Summary

Palatoplasty is a surgical procedure performed to restore palatal continuity and improve velopharyngeal function in patients with cleft palate. However, postoperative wound healing may influence scar formation, tissue quality, and maxillary growth. Various topical dressings have been used to reduce bacterial colonization and enhance tissue healing. Trigona sp. honey possesses antimicrobial, antioxidant, and anti-inflammatory properties that may promote wound healing, while framycetin sulfate is a commonly used aminoglycoside antibiotic dressing in palatoplasty. In addition, the buccal fat pad technique may improve tissue vascularization and epithelialization. This pilot randomized clinical study aims to evaluate salivary α-amylase levels as a non-invasive biomarker of wound healing in post-palatoplasty patients receiving Trigona sp. honey or framycetin sulfate dressings, with or without buccal fat pad application. Salivary α-amylase levels will be measured preoperatively and on the fourth and seventh days postoperatively to assess inflammatory responses and healing dynamics following surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 6, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 14, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 28, 2026

Completed
Last Updated

May 28, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

May 14, 2026

Last Update Submit

May 22, 2026

Conditions

Keywords

buccal fat padcleft palateframycetin sulfatehoneysalivary alpha-amylase

Outcome Measures

Primary Outcomes (1)

  • Change in Salivary α-Amylase Levels Following Palatoplasty

    Salivary α-amylase levels will be measured using ELISA analysis to evaluate postoperative inflammatory response and wound healing following the application of (1) Trigona sp honey dressing with the buccal fat pad technique, (2) Trigona sp honey dressing without the buccal fat pad technique, (3) framycetin sulfate dressing with the buccal fat pad technique, (4) framycetin sulfate dressing with the buccal fat pad technique in post-palatoplasty patients.

    Preoperative baseline, postoperative day 4, and postoperative day 7

Study Arms (4)

Trigona sp. honey dressing with the buccal fat pad technique

EXPERIMENTAL

Participants in this arm underwent palatoplasty using the two-flap push-back technique under general anesthesia followed by trigona sp honey dressing with the use of the buccal fat pad technique

Combination Product: Trigona sp honey with the buccal fat pad technique

Trigona sp. honey dressing without the buccal fat pad technique

EXPERIMENTAL

Participants in this arm underwent palatoplasty using the two-flap push-back technique under general anesthesia followed by trigona sp honey dressing

Dietary Supplement: Trigona sp. honey dressing without the buccal fat pad technique

framicetyn sulfate dressing with the buccal fat pad technique

EXPERIMENTAL

Participants in this arm underwent palatoplasty using the two-flap push-back technique under general anesthesia followed by framicetyn sulfate dressing with the use of the buccal fat pad technique

Combination Product: framicetyn sulfate dressing with the buccal fat pad technique

framicetyn sulfate dressing without the buccal fat pad technique

EXPERIMENTAL

Participants in this arm underwent palatoplasty using the two-flap push-back technique under general anesthesia followed by framicetyn sulfate dressing

Drug: framicetyn sulfate dressing without the buccal fat pad technique

Interventions

a species of stingless bee with the most significant composition of coconut pollen. This honey is one of the natural bioactive ingredients being researched and developed at Hasanuddin University. This honey has gone through the inspection process at the BPOM (Food and Drug Regulatory Agency) and is the standard for food and drug control in Indonesia. the amount of honey applied was ± 5 ml with a note: the condition of the honey absorbs all sides of the sterile gauze, then fixed with an obturator. The buccal fat pad is a complex structure associated with important anatomical structures such as the facial nerve, parotid gland, and masticatory muscles. After oral mucosa sutures, the buccal fat pad was retracted and sutured to the lateral defect

Also known as: stingless bee
Trigona sp. honey dressing with the buccal fat pad technique

The dressing commonly used in palatoplasty is framycetin sulfate (Darya-Varia Laboratory, Gunung Putri, Bogor, Indonesia) , an aminoglycoside antibiotic that works by inhibiting bacterial protein synthesis. framicetyn sulfate was applied according to the size of the obturator to be fixed. The buccal fat pad is a complex structure associated with important anatomical structures such as the facial nerve, parotid gland, and masticatory muscles. After oral mucosa sutures, the buccal fat pad was retracted and sutured to the lateral defect

Also known as: sufratulle
framicetyn sulfate dressing with the buccal fat pad technique

a species of stingless bee with the most significant composition of coconut pollen. This honey is one of the natural bioactive ingredients being researched and developed at Hasanuddin University. This honey has gone through the inspection process at the BPOM (Food and Drug Regulatory Agency) and is the standard for food and drug control in Indonesia. the amount of honey applied was ± 5 ml with a note: the condition of the honey absorbs all sides of the sterile gauze, then fixed with an obturator

Also known as: stingless bee
Trigona sp. honey dressing without the buccal fat pad technique

The dressing commonly used in palatoplasty is framycetin sulfate (Darya-Varia Laboratory, Gunung Putri, Bogor, Indonesia) , an aminoglycoside antibiotic that works by inhibiting bacterial protein synthesis. framicetyn sulfate was applied according to the size of the obturator to be fixed.

Also known as: sufratulle
framicetyn sulfate dressing without the buccal fat pad technique

Eligibility Criteria

Age18 Months - 78 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • a diagnosis of unilateral cleft palate aged 18 months to 6,5 years.
  • Patients undergoing palatoplasty surgery between June 2024 and June 2025 at Hasanuddin University Dental Hospital and Celebes Cleft Centre Foundation, Makassar, Indonesia
  • all participants parents agreed and signed an informed consent form to participate in examinations and evaluations through to the end of the study in accordance with research procedures

You may not qualify if:

  • a history of systemic disease,
  • allergies to honey ingredients,
  • failure to follow the examination and evaluation until the end according to the research procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasanuddin University Dental Hospital

Makassar, South Sulawesi, 90245, Indonesia

Location

MeSH Terms

Conditions

Cleft Palate

Condition Hierarchy (Ancestors)

Jaw AbnormalitiesJaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesStomatognathic DiseasesMouth AbnormalitiesMouth DiseasesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • abul Fauzi, DDS., MDS

    Department of Oral and Maxillofacial Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Not applicable. No masking was applied in this study
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: Four arms factorials pilot randomized clinical study comparing -amylase level as a marker of wound healing following Trigona sp. honey and framycetin sulfate with or without buccal fat pad in post-palataloplasty patients
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Director / Sub-Investigator

Study Record Dates

First Submitted

May 14, 2026

First Posted

May 28, 2026

Study Start

June 1, 2024

Primary Completion

June 1, 2025

Study Completion

August 6, 2025

Last Updated

May 28, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

The IPD will not be shared because the researchers have guaranteed the confidentiality of patient data

Locations